{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2018", "item": "https://www.patentleaderboard.com/2018/"}, {"@type": "ListItem", "position": 3, "name": "Merck", "item": "https://www.patentleaderboard.com/2018/company/merck"}, {"@type": "ListItem", "position": 4, "name": "Jongwon Lim", "item": "https://www.patentleaderboard.com/2018/inventor/fl:jo_ln:lim-222"}]}

Home › 2018 › Merck › Jongwon Lim

JL

Jongwon Lim — 10 Patents in 2018

Merck: 10 patents #8 of 1,083Top 1%

Lexington, MA: #7 of 452 inventorsTop 2%

Massachusetts: #109 of 12,682 inventorsTop 1%

Overall (2018): #6,669 of 503,207Top 2%

10 Patents 2018

Issued Patents 2018

Showing 1–10 of 10 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10155765	Carboxamide inhibitors of IRAK4 activity	Michael D. Altman, Matthew L. Childers, Craig R. Gibeau, Ginny D. Ho, Honchung Tsui	2018-12-18	$82,327,000
10106574	Cyclic di-nucleotide compounds as sting agonists	Michael D. Altman, Wonsuk Chang, Jared N. Cumming, Rui Liang, Tony Siu +3 more	2018-10-23	$118,425,000
10065967	Compounds that are ERK inhibitors	Xianhai Huang, Ronald D. Ferguson, Wei Zhou, Christopher W. Boyce, Phieng Siliphaivanh +4 more	2018-09-04	$106,918,000
10040798	Pyrrolopyridazine inhibitors of IRAK4 activity	Michael D. Altman, Jason D. Brubaker, Craig R. Gibeau	2018-08-07	$151,609,000
10040802	Thienopyrazine inhibitors of IRAK4 activity	Michael D. Altman, Craig R. Gibeau	2018-08-07	$151,609,000
9969749	Inhibitors of IRAK4 activity	Michael D. Altman, Brian M. Andresen, Jason D. Brubaker, Matthew L. Childers, Anthony Donofrio +9 more	2018-05-15	$97,235,000
9943516	Inhibitors of IRAK4 activity	Michael D. Altman, Brian M. Andresen, Jason D. Brubaker, Anthony Donofrio, Thierry O. Fischmann +8 more	2018-04-17	$82,364,000
9932350	Inhibitors of IRAK4 activity	Michael D. Altman, Jason D. Brubaker, Matthew L. Childers, Anthony Donofrio, Thierry O. Fischmann +8 more	2018-04-03	$81,854,000
9926330	Inhibitors of IRAK4 activity	Michael D. Altman, Jason D. Brubaker, Matthew L. Childers, Anthony Donofrio, Thierry O. Fischmann +8 more	2018-03-27	$54,851,000
9884048	ERK inhibitors	Phieng Siliphaivanh, Joey L. Methot, Kathryn Lipford, Danielle F. Molinari, David L. Sloman +11 more	2018-02-06	$115,479,000